Jane Street Group, LLC Ironwood Pharmaceuticals Inc Put Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	SELL	$10.61 - $12.88 $105,039 - $127,512	-9,900 Reduced 41.08%	14,200 $179,000
Q4 2021 Feb 15, 2022	SELL	$10.86 - $13.95 $184,620 - $237,150	-17,000 Reduced 41.36%	24,100 $281,000
Q3 2021 Nov 16, 2021	SELL	$11.92 - $13.92 $40,528 - $47,328	-3,400 Reduced 7.64%	41,100 $537,000
Q2 2021 Aug 16, 2021	SELL	$10.16 - $13.11 $215,392 - $277,932	-21,200 Reduced 32.27%	44,500 $573,000
Q1 2021 May 18, 2021	BUY	$9.04 - $11.86 $349,847 - $458,982	38,700 Added 143.33%	65,700 $735,000
Q3 2020 Nov 17, 2020	BUY	$8.99 - $10.74 $242,730 - $289,980	27,000 New	27,000 $243,000

237

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $706M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.